Title: To assess the prevalence of dry eye disease in postmenopausal females in a tertiary care centre in Central India

Authors: Dr Neha Adlakha, Dr Eva Rani Tirkey, Dr Sujata Lakhtakia

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i10.92

Abstract

Dry eye is disorder due to deficiency of tear film and is common amongst postmenopausal women. Aim is to establish occurrence and prevalence of dry eye in postmenopausal women in tertiary care centre in Central India. A Cross-sectional study was carried out on 150 post-menopausal women. All patients were recorded in a predesigned proforma and Ocular Surface Disease Index scoring was done. Visual acuity was assessed on Snellen’s chart and anterior segment evaluation was done using slit lamp biomicroscopy.Dry eye evaluation was done with Schirmer Test 1 and Tear film Break-Up time test. Corneal and conjunctival staining using flouroscein and Rose Bengal was performed. Assessment of meibomian gland function and grading of dry eye was done according to DEWS classification. Data was analyzed using Sta­tistical Package for Social Science (SPSS) standard version 13.0. T test. Chi square and Pearson correlation test was used for data analysis. Fifty two out of 150 post-menopausal women (34.6%) were found to have dry eyes. Prevalence of dry eye was maximum in age group>74 years (38.46%). Meibomian gland scores were normal in 28.84% of patients and abnormal in 71.15% patients. Most patients in present study had evaporative dry eye(46.15%),followed by mixed type(40.38%) and aqueous deficient(13.46%).Most of the patients in our study had mild dry eye(44.23%),followed by severe(32.69%) and 23.07% accounting for moderate dry eye. Present study reveal that dry eye symptoms are common problems in postmenopausal women. Hence, examination for dry eye should be integral part of postmenopausal women especially those having dry eye symptoms. It is important for primary care physicians to understand DED due to its high prevalence and potentially preventable and treatable nature of the condition.

Keywords: Dry eye, meibomian, tear film, postmenopausal, prevalence, Schirmer’s test.

References

  1. Sihota R, Tandon R. Systemic Ophthalmology. In: Sihota R, Tandon R, editors. Parson’s Diseases of the Eye, 21st ed. New Delhi: Elsevier; 11.p.463-464
  2. Lemp MA. Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes. CLAO J 1995;21:221-32
  3. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007).Ocul Surf 2007;5:75‑92
  4. Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan: The Shihpai Eye Study. Ophthalmology 2003 ;110:1096‑101
  5. Ozcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm. 2007 Sep-Oct; 15 (5): 389-93.
  6. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;136:318‑26
  7. Ablamowicz AF, Nichols JJ, Nichols KK. Association between serum levels of testosterone and estradiol with meibomian gland assessments in postmenopausal women. Invest Ophthalmol Vis Sci 2016;57:295‑300
  8. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21(4):221–32
  9. Genazzani AR, Nicolucci A, Campagnoli C, Crosignani P, Nappi C, Serra GB, et al. Assessment of the QoL in Italian menopausal women: comparison between HRT users and non-users. Maturitas 2002;42(4):267–80.
  10. Dawson T. Testosterone eye drops: A novel treatment for dry eye disease. Ophthalmology Times; 2015.
  11. Suzuki T, Schirra F, Richards SM, Jensen RV, Sullivan DA.Estrogen and progesterone control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci2008;49:1797‑808
  12. Conner CG. Symptomatic relief of dry eye assessed with the OSDI in patients using 5% testosterone cream. Invest Ophthalmol Vis Sci 2005;46:2032.
  13. Dawson T. Testosterone eye drops: A novel treatment for dry eye disease. Ophthalmology Times; 2015
  14. Shaharuddin B, Ismail-Mokhtar S, Hussein E. Dry eye in post-menopausal Asian women on hormone replacement therapy. Int J Ophthalmol 2008; 1: 158–160
  15. Anshu Sahai, MS; Pankaj Malik, DNB. Dry eye: Prevalence and attributable risk factors in a hospital based population. Indian Journal of Ophthalmology 2005;53:87-91
  16. Mathers WD, Daley TE. Tear flow and evaporation in patients with and without dry eye. 1996;103:664–669
  17. Uchino M Dogru M Yagi Y The features of dry eye disease in a Japanese elderly population. Optom Vis Sci . 2006; 83: 797–802
  18. Narayanan S, Redfern RL, Miller WL, Nichols KK, McDermott AM. Dry eye disease and microbial keratitis: is there a connection? Ocul Surf. 2013;11(2):75–92
  19. Sullivan, D. A., Sullivan, B. D., Evans, J. E., Schirra, F., Yamagami, H., Liu, M., Richards, S. M., Suzuki, T., Schaumberg, D. A., Sullivan, R. M. And Dana, M. R. (2002), Androgen Deficiency, Meibomian Gland Dysfunction, and Evaporative Dry Eye. Annals of the New York Academy of Sciences, 966: 211–222
  20. Caterina Gagliano, Salvatore Caruso, Giuseppe Napolitano, Giulia Malagu-arnera. Low levels of 17-β-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women: a case–control study. Br J Ophthalmol 2014; 98: 371-376.

Corresponding Author

Dr Neha Adlakha

Address-House No-1544, Sector-7 Extension, Gurgaon (Haryana)-122001 India

Mobile number-8223856309, Email: This email address is being protected from spambots. You need JavaScript enabled to view it.